MONAMI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.156
EU - Europa 5.309
AS - Asia 4.797
SA - Sud America 881
AF - Africa 138
OC - Oceania 67
Continente sconosciuto - Info sul continente non disponibili 4
Totale 22.352
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.043
RU - Federazione Russa 2.463
SG - Singapore 1.321
CN - Cina 1.055
HK - Hong Kong 887
BR - Brasile 714
PL - Polonia 697
VN - Vietnam 579
IE - Irlanda 534
IT - Italia 477
KR - Corea 363
SE - Svezia 327
FR - Francia 215
DE - Germania 183
FI - Finlandia 181
IN - India 159
JO - Giordania 81
GB - Regno Unito 70
AU - Australia 65
AR - Argentina 63
ID - Indonesia 55
CA - Canada 51
BD - Bangladesh 46
IQ - Iraq 44
JP - Giappone 43
TR - Turchia 43
UA - Ucraina 43
EC - Ecuador 41
MX - Messico 41
CH - Svizzera 40
CI - Costa d'Avorio 32
ZA - Sudafrica 31
ES - Italia 20
NL - Olanda 18
MA - Marocco 16
PY - Paraguay 16
CO - Colombia 14
PH - Filippine 14
SA - Arabia Saudita 14
PK - Pakistan 13
VE - Venezuela 12
CL - Cile 11
EG - Egitto 11
NG - Nigeria 11
AZ - Azerbaigian 10
UZ - Uzbekistan 10
DZ - Algeria 9
KZ - Kazakistan 8
LT - Lituania 8
AE - Emirati Arabi Uniti 6
BE - Belgio 6
DO - Repubblica Dominicana 6
IR - Iran 6
KE - Kenya 6
NP - Nepal 6
TN - Tunisia 6
AL - Albania 5
BJ - Benin 5
PE - Perù 5
UY - Uruguay 5
BH - Bahrain 4
IL - Israele 4
MY - Malesia 4
DK - Danimarca 3
HN - Honduras 3
LV - Lettonia 3
PS - Palestinian Territory 3
PT - Portogallo 3
SC - Seychelles 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
BY - Bielorussia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
JM - Giamaica 2
MD - Moldavia 2
MM - Myanmar 2
MN - Mongolia 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
QA - Qatar 2
SI - Slovenia 2
SN - Senegal 2
TH - Thailandia 2
AT - Austria 1
BG - Bulgaria 1
BW - Botswana 1
CY - Cipro 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
Totale 22.342
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.421
Ashburn 1.312
Fairfield 1.096
Singapore 962
Hong Kong 769
Warsaw 693
Dublin 532
Chandler 526
Woodbridge 495
Seattle 485
Cambridge 412
Houston 379
Seoul 356
Wilmington 342
Beijing 295
San Jose 295
Lawrence 225
Altamura 224
Ho Chi Minh City 204
Ann Arbor 192
Moscow 184
Princeton 169
The Dalles 140
Hanoi 139
Buffalo 136
Lauterbourg 134
Los Angeles 134
Mumbai 113
Hefei 110
Boston 99
Munich 84
New York 84
San Diego 79
Boardman 78
Medford 72
Helsinki 68
Florence 65
Shanghai 62
São Paulo 61
Dallas 58
Melbourne 56
Council Bluffs 53
Clifton 47
Paris 47
Kent 43
Bern 34
Tokyo 34
Jacksonville 33
Abidjan 32
Turku 32
Falls Church 29
Redondo Beach 28
Toronto 28
Izmir 27
Jakarta 27
Rio de Janeiro 27
Guangzhou 23
Orem 23
Andover 22
Hillsboro 22
London 21
Frankfurt am Main 20
Baghdad 18
Da Nang 18
Tianjin 18
Norwalk 17
Biên Hòa 15
Curitiba 15
Quito 15
Falkenstein 14
Lappeenranta 14
Phoenix 14
Rome 14
Belo Horizonte 13
Brooklyn 13
Guayaquil 13
Johannesburg 13
Dong Ket 12
Haiphong 12
Mexico City 12
Milan 12
Porto Alegre 12
Thái Nguyên 12
Amman 11
Brasília 11
Chicago 11
Redmond 11
Redwood City 11
Abuja 10
Atlanta 10
Montreal 10
Yubileyny 10
Hải Dương 9
Salvador 9
Shenzhen 9
Baku 8
Can Tho 8
Caxias do Sul 8
Fortaleza 8
Goiânia 8
Totale 15.450
Salva come PNG Salva come JPEG
Nome #
Left ventricular cavity obliteration during dobutamine stress echocardiography in diabetic patients 323
Resistin level in coronary artery disease and heart failure: the central role of kidney function 318
Glucagon-Like Peptide-1, Diabetes, and Cognitive Decline: Possible Pathophysiological Links and Therapeutic Opportunities 317
Sulphonylureas and cancer: a case-control study. 272
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis. 236
Adjustment of insulin doses when switching from glargine 100 U/ml or detemir to degludec: an observational study. 230
Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events: A comprehensive meta-analysis of randomized controlled trials 212
Are psychopathological features relevant predictors of glucose control in patients with type 2 diabetes? A prospective study 210
Prolactin levels independently predict major cardiovascular events in patients with erectile dysfunction 209
A randomized, open-label, controlled trial to evaluate the antimicrobial and surgical effect of CO2 laser treatment in diabetic infected foot ulcers: DULCIS (diabetic ulcer, CO2 laser, and infections) study 209
DPP-4 inhibitors and lipids: Systematic review and meta-analysis 197
Glucose control in diabetes during home confinement for the first pandemic wave of COVID-19: a meta-analysis of observational studies 195
Amphetamine derivatives and obesity 194
Age and comorbidity in acute myocardial infarction: a report from the AMI-Florence Italian registry 188
Alternative treatment or alternative to treatment? A systematic review of randomized trials on homeopathic preparations for diabetes and obesity 185
Adjustment of insulin doses when switching from glargine 100 U/ml or detemir to degludec: an observational study 185
Impairment of couple relationship in male patients with sexual dysfunction is associated with overt hypogonadism. 179
Adherence to and early adverse events of COVID-19 vaccine in a cohort of 600 Italian breastfeeding and pregnant physicians 178
Is obesity a further cardiovascular risk factor in patients with erectile dysfunction? 178
Fasting and post-prandial glucose and diabetic complication. A meta-analysis 177
Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily 177
Targeting educational therapy for type 2 diabetes: Identification of predictors of therapeutic success 176
Effects on lipid profile of dipeptidyl peptidase 4 inhibitors, pioglitazone, acarbose, and sulfonylureas: Meta-analysis of placebo-controlled trials 175
Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials 175
HbA1c levels and all-cause mortality in type 2 diabetic patients: Epidemiological evidence of the need for personalised therapeutic targets 173
Priapus is Happier with Venus than with Bacchus 171
Effect of insulin secretagogues on major cardiovascular events and all-cause mortality: A meta-analysis of randomized controlled trials 171
Effects of PCSK9 inhibitors on LDL cholesterol, cardiovascular morbidity and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials 170
Low Testosterone is Associated with an Increased Risk of MACE Lethality in Subjects with Erectile Dysfunction 170
Effects of SGLT-2 inhibitors on diabetic ketoacidosis: A meta-analysis of randomised controlled trials 170
Alpha-Tocopherol and contrast-induced nephropathy: a meta-analysis of randomized controlled trials 168
Impact of influenza vaccination on all-cause mortality and hospitalization for pneumonia in adults and the elderly with diabetes: A meta-analysis of observational studies 167
CO2 laser for the treatment of diabetic foot ulcers with exposed bone. A consecutive series of type 2 diabetic patients 167
Factors associated with increased all-cause mortality during the COVID-19 pandemic in Italy 166
Glucagon-like peptide-1 response to meals and post-prandial hyperglycemia in Type 2 diabetic patients. 165
Back to glycemic control: An alternative look at the results of cardiovascular outcome trials in type 2 diabetes 164
Toe amputations with SGLT-2 inhibitors: data from randomized clinical trials 163
Glucagon-like peptide-1 receptor agonists and risk of thyroid cancer: A systematic review and meta-analysis of randomized controlled trials 162
Failure to metformin and insulin secretagogue monotherapy: an observational cohort study. 162
2023 update on Italian guidelines for the treatment of type 2 diabetes 161
Development of the Italian Clinical Practice Guidelines on Bariatric and Metabolic Surgery: Design and Methodological Aspects 161
Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study. 161
Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. 160
Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials 160
Glucagon-like peptide-1 receptor agonists and atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials 159
Antimicrobial photodynamic therapy in infected diabetic foot ulcers: A multicenter preliminary experience 159
Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized controlled trials 158
Immune checkpoints inhibitors and hyperglycemia: A Meta-analysis of randomized controlled trials 158
Post-prandial glucose and diabetic complications: Systematic review of observational studies 157
All-cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanides. 156
Type 1 diabetes and periodontitis: prevalence and periodontal destruction—a systematic review 155
Dipeptidyl peptidase-4 inhibitors and bone fractures: A meta-analysis of randomized clinical trials 154
Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: A meta-analysis of randomized controlled trials 154
Metabolic surgery for the treatment of type 2 diabetes: A network meta-analysis of randomized controlled trials 154
All-cause and cardiovascular mortality in a consecutive series of patients with diabetic foot osteomyelitis 152
Treatment with insulin secretagogues and cancer-related mortality in type 2 diabetic patients a retrospective cohort study. 151
Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: A meta-analysis of randomized clinical trials 151
Cardiovascular Safety of Incretin-Based Therapies in Type 2 Diabetes: Systematic Review of Integrated Analyses and Randomized Controlled Trials 151
Exploring the heterogeneity of the effects of SGLT-2 inhibitors in cardiovascular outcome trials 150
Glucagon-like peptide-1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta-analysis and subgroup analysis of randomized controlled trials 149
Retrospective Matched Case-Control Study on the Use of CO2 Laser for the Treatment of Nonhealing Diabetic Foot Ulcers: The DULCIS-2 (Diabetic ULcer, CO2 Laser, and Infections) Study 149
Deprescription in elderly patients with type 2 diabetes mellitus 148
Glomerular hyperfiltration and metabolic syndrome: results from the FIrenze-BAgno A Ripoli (FIBAR) Study 148
Bariatric Surgery for Patients with Overweight/Obesity. A Comprehensive Grading Methodology and Network Metanalysis of Randomized Controlled Trials on Weight Loss Outcomes and Adverse Events 146
combined continuous glucose monitoring and subcutaneous insulin infusion versus self‐monitoring of blood glucose with optimized multiple injections in type 1 diabetes: A randomized cross‐over trial 146
Association between different screening strategies for SARS-CoV-2 and deaths and severe disease in Italy 146
Bone Fractures with Sodium-Glucose Co-transporter-2 Inhibitors: How Real is the Risk? 146
Coronary artery disease screening in type II diabetic patients: Prognostic value of rest and stress echocardiography 144
Peripheral artery disease and amputations with Sodium-Glucose co-Transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials 144
Bypass surgery versus endovascular revascularization for occlusive infrainguinal peripheral artery disease: a meta-analysis of randomized controlled trials for the development of the Italian Guidelines for the treatment of diabetic foot syndrome 143
Potential Impact of Climate on Novel Corona Virus (COVID-19) Epidemic 143
Efficacy and safety of different basal and prandial insulin analogues for the treatment of type 2 diabetes: a network meta-analysis of randomized controlled trials 143
Safety of dipeptidyl peptidase-4 inhibitors: A meta-analysis of randomized clinical trials 142
Low diastolic ambulatory blood pressure is associated with greater all-cause mortality in older patients with hypertension 142
Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: An updated meta-analysis of randomized controlled trials 142
Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials 142
Effectiveness of pneumococcal vaccination on hospitalization and death in the adult and older adult diabetic population: a systematic review 141
Severe Depressive Symptoms and Cardiovascular Risk in Subjects with Erectile Dysfunction 141
Reply to Gaertner, K. and Frass, M 141
Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials. 141
Dypeptidylpeptidase-4 inhibitors and the cardiovascular system: How to manage the fil rouge 139
Pancreatitis and pancreatic cancer in patientes treated with Dipeptidyl Peptidase-4 inhibitors: An extensive and updated meta-analysis of randomized controlled trials 139
All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials 139
Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials 138
Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients. 137
Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials 137
Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials 137
Efficacy and effects of bariatric surgery in the treatment of obesity: Network meta-analysis of randomized controlled trials 137
Major Amputation In Non-Healing Ulcers: Outcomes and Economic Issues. Data from a Cohort of Patients with Diabetic Foot Ulcers 136
Rosiglitazone and cardiovascular risk. 135
Sars-CoV2 vaccine hesitancy in Italy: A survey on subjects with diabetes 135
Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS) 135
Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials 134
Doses of insulin and its analogues and cancer occurence in insulin-treated type 2 diabetic patients. 133
Efficacy and safety of glucose-lowering agents in patients with type 2 diabetes: A network meta-analysis of randomized, active comparator-controlled trials 132
[Psychological disorders and cardiovascular diseases] 131
Hypertension and metabolic syndrome in the elderly 130
Autologous Peripheral Blood Mononuclear Cells in Patients with Small Artery Disease and Diabetic Foot Ulcers: Efficacy, Safety, and Economic Evaluation 129
Attending Diabetes Clinics is associated with a lower all-cause mortality. A meta-analysis of observational studies performed in Italy 129
Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials 128
Totale 16.443
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.478
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.478
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021165 0 0 0 0 0 0 0 0 0 0 95 70
2021/2022985 30 62 106 59 33 53 37 73 46 52 137 297
2022/20232.541 300 615 119 183 129 406 292 92 251 20 81 53
2023/2024880 42 92 152 47 54 76 44 172 22 85 62 32
2024/20256.929 219 733 449 1.042 2.042 885 101 484 347 173 224 230
2025/20266.565 759 990 572 711 966 288 850 447 473 435 74 0
Totale 22.512